Aldeyra Therapeutics, Inc.
ALDX· Nasdaq
Aldeyra Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -9.30%
- Market cap
- $70.58M
- 60.33M shares
- Filings
- 646
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $25,662,855 | reported | |
| FY 2024 | 2024-12-31 | $48,224,793 | reported | |
| FY 2023 | 2023-12-31 | $29,458,719 | reported | |
| FY 2022 | 2022-12-31 | $47,306,066 | reported | |
| FY 2021 | 2021-12-31 | $44,936,532 | reported | |
| FY 2020 | 2020-12-31 | $24,681,301 | reported | |
| FY 2019 | 2019-12-31 | $44,351,851 | reported | |
| FY 2018 | 2018-12-31 | $29,823,007 | reported | |
| FY 2017 | 2017-12-31 | $16,302,568 | reported | |
| FY 2016 | 2016-12-31 | $13,175,670 | reported | |
| FY 2015 | 2015-12-31 | $7,574,398 | reported | |
| FY 2014 | 2014-12-31 | $3,707,544 | reported |
Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR
